| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.09 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |